Hélène Dreyfus

1.1k total citations
14 papers, 341 citations indexed

About

Hélène Dreyfus is a scholar working on Genetics, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hélène Dreyfus has authored 14 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Cancer Research and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hélène Dreyfus's work include BRCA gene mutations in cancer (6 papers), Breast Cancer Treatment Studies (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Hélène Dreyfus is often cited by papers focused on BRCA gene mutations in cancer (6 papers), Breast Cancer Treatment Studies (4 papers) and Acute Lymphoblastic Leukemia research (3 papers). Hélène Dreyfus collaborates with scholars based in France, Tunisia and United States. Hélène Dreyfus's co-authors include Alain Fourquet, Bernard Asselain, Chantal Gautier, Dominique Stoppa‐Lyonnet, François Campana, E. Bourstyn, P Pouillart, Anne Vincent‐Salomon, Y. Ansquer and Youlia Kirova and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Hélène Dreyfus

13 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hélène Dreyfus France	8	200	162	108	86	72	14	341
Anthony Dragun United States	6	107 0.5×	130 0.8×	86 0.8×	48 0.6×	63 0.9×	16	257
J-Y Pierga France	10	290 1.4×	75 0.5×	215 2.0×	116 1.3×	103 1.4×	17	450
CW Elston United Kingdom	6	276 1.4×	120 0.7×	223 2.1×	143 1.7×	45 0.6×	8	398
S. Heymann France	12	236 1.2×	67 0.4×	178 1.6×	83 1.0×	65 0.9×	33	450
Chantal Gautier France	9	424 2.1×	120 0.7×	198 1.8×	260 3.0×	58 0.8×	17	542
Rachel Würstlein Germany	9	138 0.7×	82 0.5×	260 2.4×	36 0.4×	58 0.8×	58	465
Don Conroy United Kingdom	5	79 0.4×	89 0.5×	77 0.7×	31 0.4×	176 2.4×	5	338
Sally B. Cheston United States	7	222 1.1×	42 0.3×	104 1.0×	83 1.0×	15 0.2×	15	321
Alberto Alvarado‐Miranda Mexico	10	162 0.8×	37 0.2×	188 1.7×	38 0.4×	63 0.9×	23	325
J. A. Andersen Denmark	5	472 2.4×	100 0.6×	300 2.8×	285 3.3×	66 0.9×	9	651

Countries citing papers authored by Hélène Dreyfus

Since Specialization

Citations

This map shows the geographic impact of Hélène Dreyfus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Dreyfus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Dreyfus more than expected).

Fields of papers citing papers by Hélène Dreyfus

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Dreyfus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Dreyfus. The network helps show where Hélène Dreyfus may publish in the future.

Co-authorship network of co-authors of Hélène Dreyfus

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Dreyfus. A scholar is included among the top collaborators of Hélène Dreyfus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Dreyfus. Hélène Dreyfus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Dreyfus, Hélène, et al.. (2024). BRCA1 Intragenic Duplication Combined with a Likely Pathogenic TP53 Variant in a Patient with Triple-Negative Breast Cancer: Clinical Risk and Management. International Journal of Molecular Sciences. 25(11). 6274–6274. 1 indexed citations

Hamadou, Walid Sabri, Nouha Bouali, Violaine Bourdon, et al.. (2021). Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies. Bulletin du Cancer. 108(9). 798–805.

Pujol, Pascal, Lise Roca, Alain Lortholary, et al.. (2020). Five year letrozole versus placebo in BRCA1/2 germline mutations carriers: Final results of LIBER, a double-blind randomized phase III breast cancer prevention trial.. Journal of Clinical Oncology. 38(15_suppl). 1534–1534. 10 indexed citations

Hamadou, Walid Sabri, Violaine Bourdon, Yosra Ben Youssef, et al.. (2017). GATA2 gene analysis in several forms of hematological malignancies including familial aggregations. Annals of Hematology. 96(10). 1635–1639. 6 indexed citations

Hamadou, Walid Sabri, Violaine Bourdon, Yosra Ben Youssef, et al.. (2016). ARLTS1, potential candidate gene in familial aggregation of hematological malignancies. Bulletin du Cancer. 104(2). 123–127. 9 indexed citations

Hamadou, Walid Sabri, Souhail Besbes, Violaine Bourdon, et al.. (2015). Familial hematological malignancies: ASXL1 gene investigation. Clinical & Translational Oncology. 18(4). 385–390. 11 indexed citations

Hassanein, Mohamed, Laëtitia Huiart, Violaine Bourdon, et al.. (2013). Prediction of BRCA1 Germ-Line Mutation Status in Patients with Breast Cancer Using Histoprognosis Grade, MS110, Lys27H3, Vimentin, and KI67. Pathobiology. 80(5). 219–227. 10 indexed citations

Julian‐Reynier, Claire, Anne‐Déborah Bouhnik, Christine Lasset, et al.. (2010). Time to prophylactic surgery in BRCA1/2 carriers depends on psychological and other characteristics. Genetics in Medicine. 12(12). 801–807. 30 indexed citations

Bourdon, Violaine, Laëtitia Huiart, François Eisinger, et al.. (2009). Molecular study of CEPBA in familial hematological malignancies. Familial Cancer. 8(4). 581–584. 4 indexed citations

10.

Campana, François, Youlia Kirova, Jean‐Claude Rosenwald, et al.. (2005). Breast radiotherapy in the lateral decubitus position: A technique to prevent lung and heart irradiation. International Journal of Radiation Oncology*Biology*Physics. 61(5). 1348–1354. 75 indexed citations

11.

Stoppa‐Lyonnet, Dominique, Y. Ansquer, Hélène Dreyfus, et al.. (2000). Familial Invasive Breast Cancers: Worse Outcome Related to BRCA1 Mutations. Journal of Clinical Oncology. 18(24). 4053–4059. 132 indexed citations

12.

Campana, F., Véronique Mosseri, Hélène Dreyfus, et al.. (1995). Breast cancer in elderly women: a retrospective analysis of combined treatment with tamoxifen and once-weekly irradiation. International Journal of Radiation Oncology*Biology*Physics. 31(4). 783–789. 46 indexed citations

13.

Dreyfus, Hélène, et al.. (1995). Management of breast cancer in the elderly. European Journal of Cancer Care. 4(2). 75–79. 4 indexed citations

14.

Dreyfus, Hélène, et al.. (1995). Management of breast cancer in the elderly. European Journal of Cancer Care. 4(s1). 75–79. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact